1. Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
    Ningni Jiang et al, 2020, Molecular Biology Reports CrossRef
  2. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells
    Chi Zhang et al, 2021, Life Sciences CrossRef
  3. DDX55 promotes hepatocellular carcinoma progression by interacting with BRD4 and participating in exosome‐mediated cell‐cell communication
    Bin Yu et al, 2022, Cancer Science CrossRef

  4. Study of the Relationship Between Serum Amino Acid Metabolism and Lymph Node Metastasis in Patients with Colorectal Cancer


    Jinhao Liu et al, 2020, OncoTargets and Therapy CrossRef
  5. JQ1, a selective inhibitor of BRD4, suppresses retinoblastoma cell growth by inducing cell cycle arrest and apoptosis
    Yanyan Zhang et al, 2021, Experimental Eye Research CrossRef
  6. The prognostic significance of bromodomain protein 4 expression in solid tumor patients: A meta-analysis
    Yueqi Wang et al, 2022, Pathology - Research and Practice CrossRef
  7. Manganese‐12 acetate suppresses the migration, invasion, and epithelial–mesenchymal transition by inhibiting Wnt/β‐catenin and PI3K/AKT signaling pathways in breast cancer cells
    Hongping Ju et al, 2018, Thoracic Cancer CrossRef
  8. Unlocking the secrets of aging: Epigenetic reader BRD4 as the target to combatting aging-related diseases
    Jiaxing Sun et al, 2023, Journal of Advanced Research CrossRef
  9. KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma
    Xiaowei Fu et al, 2018, International Journal of Oncology CrossRef
  10. Inhibition of Brd4 alleviates renal ischemia/reperfusion injury-induced apoptosis and endoplasmic reticulum stress by blocking FoxO4-mediated oxidative stress
    Hao Liu et al, 2019, Redox Biology CrossRef
  11. Bromodomain and extraterminal domain inhibitor enhances the antitumor effect of imatinib in gastrointestinal stromal tumours
    Jianfeng Mu et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
  12. PCAT6 May Be a Whistler and Checkpoint Target for Precision Therapy in Human Cancers
    Feng Jiang et al, 2021, Cancers CrossRef
  13. BRD4 inhibitor and histone deacetylase inhibitor synergistically inhibit the proliferation of gallbladder cancer in vitro and in vivo
    Shilei Liu et al, 2019, Cancer Science CrossRef
  14. Apigenin suppresses proliferation, invasion, and epithelial–mesenchymal transition of cervical carcinoma cells by regulation of miR‐152/BRD4 axis
    Xia Zhao et al, 2021, The Kaohsiung Journal of Medical Sciences CrossRef
  15. Dual‐target inhibitors of bromodomain and extra‐terminal proteins in cancer: A review from medicinal chemistry perspectives
    Lu Feng et al, 2022, Medicinal Research Reviews CrossRef
  16. NONO promotes gallbladder cancer cell proliferation by enhancing oncogenic RNA splicing of DLG1 through interaction with IGF2BP3/RBM14
    Zi-yi Yang et al, 2024, Cancer Letters CrossRef
  17. A Bromodomain-Containing Protein 4 (BRD4) Inhibitor Suppresses Angiogenesis by Regulating AP-1 Expression
    Zijun Zhou et al, 2020, Frontiers in Pharmacology CrossRef
  18. HMGA2 promotes the migration and invasion of gallbladder cancer cells and HMGA2 knockdown inhibits angiogenesis via targeting VEGFA
    Jun Yan et al, 2021, Molecular Medicine Reports CrossRef
  19. JQ1 and PI3K inhibition synergistically reduce salivary adenoid cystic carcinoma malignancy by targeting the c‐Myc and EGFR signaling pathways
    Xiaojing Liu et al, 2019, Journal of Oral Pathology & Medicine CrossRef
  20. Pyronaridine as a Bromodomain-Containing Protein 4-N-Terminal Bromodomain (BRD4-BD1) Inhibitor: In Silico Database Mining, Molecular Docking, and Molecular Dynamics Simulation
    Mahmoud A. A. Ibrahim et al, 2023, Molecules CrossRef
  21. Self-assembled redox-responsive BRD4 siRNA nanoparticles: fomulation and its in vitro delivery in gastric cancer cells
    Mengying Zhang et al, 2024, Journal of Chemotherapy CrossRef
  22. Targeting phosphoinositide‐3‐kinase pathway in biliary tract cancers: A remedial route?
    Jayaramayya Kaavya et al, 2019, Journal of Cellular Physiology CrossRef
  23. Knockdown of TRIM31 suppresses proliferation and invasion of gallbladder cancer cells by down-regulating MMP2/9 through the PI3K/Akt signaling pathway
    Hui Li et al, 2018, Biomedicine & Pharmacotherapy CrossRef